Literature DB >> 30847396

Analysis of Hormone Receptor Status in Primary and Recurrent Breast Cancer Via Data Mining Pathology Reports.

Kai-Po Chang1,2, Yen-Wei Chu3,4, John Wang1.   

Abstract

BACKGROUND: Hormone receptors of breast cancer, such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her-2), are important prognostic factors for breast cancer.
OBJECTIVE: The current study aimed to develop a method to retrieve the statistics of hormone receptor expression status, documented in pathology reports, given their importance in research for primary and recurrent breast cancer, and quality management of pathology laboratories.
METHOD: A two-stage text mining approach via regular expression-based word/phrase matching, was developed to retrieve the data.
RESULTS: The method achieved a sensitivity of 98.8%, 98.7% and 98.4% for extraction of ER, PR, and Her-2 results. The hormone expression status from 3679 primary and 44 recurrent breast cancer cases was successfully retrieved with the method. Statistical analysis of these data showed that the recurrent disease had a significantly lower positivity rate for ER (54.5% vs 76.5%, p=0.001278) than primary breast cancer and a higher positivity rate for Her-2 (48.8% vs 16.2%, p=9.79e-8). These results corroborated the previous literature.
CONCLUSION: Text mining on pathology reports using the developed method may benefit research of primary and recurrent breast cancer.

Entities:  

Keywords:  Breast cancer; Hormone receptor; Primary cancer; Recurrent cancer; Text mining

Year:  2019        PMID: 30847396      PMCID: PMC6401490          DOI: 10.1515/med-2019-0013

Source DB:  PubMed          Journal:  Open Med (Wars)


  25 in total

1.  Synoptic/checklist reporting of breast biopsies: has the time come?

Authors:  A S Leong
Journal:  Breast J       Date:  2001 Jul-Aug       Impact factor: 2.431

2.  Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program.

Authors:  A R Aronson
Journal:  Proc AMIA Symp       Date:  2001

Review 3.  HER2 testing in breast cancer: NCCN Task Force report and recommendations.

Authors:  Robert W Carlson; Susan J Moench; M Elizabeth H Hammond; Edith A Perez; Harold J Burstein; D Craig Allred; Charles L Vogel; Lori J Goldstein; George Somlo; William J Gradishar; Clifford A Hudis; Mohammad Jahanzeb; Azadeh Stark; Antonio C Wolff; Michael F Press; Eric P Winer; Soonmyung Paik; Britt-Marie Ljung
Journal:  J Natl Compr Canc Netw       Date:  2006-07       Impact factor: 11.908

4.  Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

Authors:  M J Ellis; A Coop; B Singh; L Mauriac; A Llombert-Cussac; F Jänicke; W R Miller; D B Evans; M Dugan; C Brady; E Quebe-Fehling; M Borgs
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

5.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.

Authors:  Mehrdad Nadji; Carmen Gomez-Fernandez; Parvin Ganjei-Azar; Azorides R Morales
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

6.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 7.  The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview.

Authors:  I D Nagtegaal; J H J M van Krieken
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

8.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

9.  Concept-match medical data scrubbing. How pathology text can be used in research.

Authors:  Jules J Berman
Journal:  Arch Pathol Lab Med       Date:  2003-06       Impact factor: 5.534

10.  Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

Authors:  Paul L Nguyen; Alphonse G Taghian; Matthew S Katz; Andrzej Niemierko; Rita F Abi Raad; Whitney L Boon; Jennifer R Bellon; Julia S Wong; Barbara L Smith; Jay R Harris
Journal:  J Clin Oncol       Date:  2008-04-14       Impact factor: 44.544

View more
  4 in total

1.  Weighing and modelling factors influencing serum cortisol and melatonin concentration among workers that are exposed to various sound pressure levels using neural network algorithm: An empirical study.

Authors:  Sajad Zare; Rasoul Hemmatjo; Hossein ElahiShirvan; Ashkan Jafari Malekabad; Reza Kazemi; Farshad Nadri
Journal:  Heliyon       Date:  2020-09-28

2.  Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports.

Authors:  Kai-Po Chang; John Wang; Chi-Chang Chang; Yen-Wei Chu
Journal:  Biomed Res Int       Date:  2020-05-23       Impact factor: 3.411

Review 3.  MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.

Authors:  Mohammad Mijanur Rahman; Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

4.  Rule-Based Information Extraction from Free-Text Pathology Reports Reveals Trends in South African Female Breast Cancer Molecular Subtypes and Ki67 Expression.

Authors:  Okechinyere J Achilonu; Elvira Singh; Gideon Nimako; René M J C Eijkemans; Eustasius Musenge
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.